2020
ADPKD, Tolvaptan, and Nephrolithiasis Risk
Publication
Publication
Clinical Journal of the American Society of Nephrology , Volume 15 - Issue 7 p. 923- 925
Additional Metadata | |
---|---|
doi.org/10.2215/cjn.07610520, hdl.handle.net/1765/130479 | |
Clinical Journal of the American Society of Nephrology | |
Organisation | Department of Internal Medicine |
Hoorn, E.J, & Zietse, R. (2020). ADPKD, Tolvaptan, and Nephrolithiasis Risk. Clinical Journal of the American Society of Nephrology, 15(7), 923–925. doi:10.2215/cjn.07610520
|